Kiran Kumar Solingapuram Sai to Treatment Outcome
This is a "connection" page, showing publications Kiran Kumar Solingapuram Sai has written about Treatment Outcome.
Connection Strength
0.066
-
Erichsen JM, Register TC, Sutphen C, Ma D, Gaussoin SA, Rudolph M, Rundle M, Bateman JT, Lockhart SN, Sai KKS, Whitlow C, Craft S. A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD. Alzheimers Dement. 2025 Oct; 21(10):e70704.
Score: 0.034
-
Kawas MI, Shamulzai A, Atcheson KM, Horn AC, Ma R, Kittel C, Curry B, Lipford M, Kim J, Solingapuram Sai KK, Wolfe SQ, Whitlow CT. Utilizing Quantitative Analysis of CSF Volume from Clinical T1-Weighted MRI to Predict Thrombectomy Outcomes. J Neuroimaging. 2025; 35(1):e70013.
Score: 0.032